PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19570880-8 2009 ATP alone increased Akt activity and this effect was significantly blocked by suramin, a P2 receptor antagonist. Suramin 78-85 thymoma viral proto-oncogene 1 Mus musculus 20-23 16916926-11 2006 ATP phosphorylated Akt and p44/42 mitogen-activated protein kinases (MAPKs) in a time-dependent manner, and either suramin or reactive blue 2 (RB2) blocked the ATP-induced phosphorylation of Akt. Suramin 115-122 thymoma viral proto-oncogene 1 Mus musculus 191-194 11294978-4 2001 Sodium fluoride (NaF) induced apoptosis in both cell types but at different concentrations, with the primary cells being more sensitive to NAF: Proliferation of the type 2 cells and A549 cells was inhibited in the presence of NAF: NaF induced a prolonged activation of MAP kinase ERK. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 11294978-4 2001 Sodium fluoride (NaF) induced apoptosis in both cell types but at different concentrations, with the primary cells being more sensitive to NAF: Proliferation of the type 2 cells and A549 cells was inhibited in the presence of NAF: NaF induced a prolonged activation of MAP kinase ERK. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 139-142 11294978-4 2001 Sodium fluoride (NaF) induced apoptosis in both cell types but at different concentrations, with the primary cells being more sensitive to NAF: Proliferation of the type 2 cells and A549 cells was inhibited in the presence of NAF: NaF induced a prolonged activation of MAP kinase ERK. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 226-229 11294978-4 2001 Sodium fluoride (NaF) induced apoptosis in both cell types but at different concentrations, with the primary cells being more sensitive to NAF: Proliferation of the type 2 cells and A549 cells was inhibited in the presence of NAF: NaF induced a prolonged activation of MAP kinase ERK. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 231-234 11746504-1 2001 The results reported here show that sodium fluoride (NaF) at low concentration (up to 10 microM) increased four times the proliferation rate of avian osteoblasts in culture. Sodium Fluoride 36-51 C-X-C motif chemokine ligand 8 Homo sapiens 53-56 11382084-2 2001 One such additive is sodium fluoride (NaF), which promotes bone formation, facilitating implant integration and success. Sodium Fluoride 21-36 C-X-C motif chemokine ligand 8 Homo sapiens 38-41 11032978-2 2000 METHODS: To test this hypothesis, the beta-adrenergic agonist, isoproterenol, and the G protein activator, sodium fluoride (NaF), were used to stimulate cAMP production in B lymphoblasts from healthy and BP-I subjects phenotyped on basal intracellular calcium concentration ([Ca(2+)](B)). Sodium Fluoride 107-122 C-X-C motif chemokine ligand 8 Homo sapiens 124-127 11014907-1 2000 Sodium monofluorophosphate (NaMFP) and sodium fluoride (NaF) are the two most common sources of fluoride used in currently marketed fluoride dentifrices. Sodium Fluoride 39-54 C-X-C motif chemokine ligand 8 Homo sapiens 56-59 10953284-5 2000 Pretreatment of poorly and highly metastatic human HT-29 colon carcinoma cells with the broad-range inhibitors sodium fluoride (NaF) and sodium pyrophosphate (PyroP) resulted in strong reduction in adhesion of HT-29 cells to various ECM components. Sodium Fluoride 111-126 C-X-C motif chemokine ligand 8 Homo sapiens 128-131 10938902-5 2000 S1P displayed a dual effect on sodium fluoride (NaF)-induced platelet aggregation and had no effect on the aggregation induced by ADP or lysophosphatidic acid (LPA). Sodium Fluoride 31-46 C-X-C motif chemokine ligand 8 Homo sapiens 48-51 10602388-4 1999 Dose-response experiments showed a maximal release of IL-6 and IL-8 at a concentration of 5 mM NaF 24 h after addition. Sodium Fluoride 95-98 C-X-C motif chemokine ligand 8 Homo sapiens 63-67 10602388-6 1999 Time-course experiments showed a NaF-induced IL-6 response at 5 h, whereas an IL-8 response was observed after 10 h. Cycloheximide treatment completely abolished the NaF-induced cytokine responses. Sodium Fluoride 166-169 C-X-C motif chemokine ligand 8 Homo sapiens 78-82 9892783-4 1999 This was tested by measuring the effect of sodium fluoride (NaF) on cytokine production by human whole blood cells stimulated in vitro. Sodium Fluoride 43-58 C-X-C motif chemokine ligand 8 Homo sapiens 60-63 10413893-1 1999 According to previous pharmacokinetic studies the bioavailability of fluorine (F) from sodium monofluorophosphate (MFP) doubles that of sodium fluoride (NaF). Sodium Fluoride 136-151 C-X-C motif chemokine ligand 8 Homo sapiens 153-156 10022774-10 1998 Prestimulation of the G-protein activity by sodium fluoride (NaF) or cholera toxin (CT), followed by rhFSH challenge, accounted for a decrease in the cAMP-mediated responsiveness, down to 69.4 +/- 2.8 or 74.2 +/- 1.9%, of control (P < 0.001), respectively, indicating that the post-receptor events are critical for desensitization. Sodium Fluoride 44-59 C-X-C motif chemokine ligand 8 Homo sapiens 61-64 9584909-3 1998 Triclosan is used in dentifrices in combination with either zinc citrate or sodium fluoride (NaF). Sodium Fluoride 76-91 C-X-C motif chemokine ligand 8 Homo sapiens 93-96 9227164-1 1997 OBJECTIVE: To investigate whether administration of sodium fluoride (NaF) in addition to cyclical etidronate has a positive effect on bone mineral density (BMD) in patients with established osteoporosis during continued treatment with corticosteroids. Sodium Fluoride 52-67 C-X-C motif chemokine ligand 8 Homo sapiens 69-72 9145235-2 1997 In clinical trials, both treatments increase bone density, although sodium fluoride (NaF) increases and alendronate (bisphosphonate, ALN) decreases bone turnover. Sodium Fluoride 68-83 C-X-C motif chemokine ligand 8 Homo sapiens 85-88 9604055-1 1997 To investigate whether sodium fluoride (NaF) is able to prevent bone loss in patients treated with corticosteroids (Cs), we performed a randomized double-masked, placebo-controlled trial with 44 Cs-treated patients without established osteoporosis, defined as the absence of previous peripheral fractures and vertebral deformities on radiographs. Sodium Fluoride 23-38 C-X-C motif chemokine ligand 8 Homo sapiens 40-43 8915775-1 1996 Sodium fluoride (NaF) is known to stimulate osteoblastic bone formation, but little attention has been given to the possibility that NaF also affects bone resorption and the differentiation of osteoclastic progenitor cells. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 8768798-6 1996 After different cellular activation either with the Ca ionophore A23187, the tripeptide formyl-methionyl-leucyl-phenylalanine (fMLP) or sodium fluoride (NaF) coincubation of PMN with APS led to a diminished generation of LTB4. Sodium Fluoride 136-151 C-X-C motif chemokine ligand 8 Homo sapiens 153-156 8812262-1 1996 Sodium fluoride (NaF; Cas No. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 8822349-1 1996 Sodium fluoride (NaF), which stimulates bone formation, and bisphosphonates, which reduce bone resorption, are both used in the treatment of osteoporosis, and are binding to bone mineral. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 8634157-1 1995 PURPOSE: To evaluate the efficacy of a sodium fluoride (NaF)/silica/xylitol dentifrice compared with that of a positive control NaF/silica dentifrice on caries increments in school children over a 3-year period in an area without an optimal level of fluoride in the drinking water (mean level <0.1 ppm). Sodium Fluoride 39-54 C-X-C motif chemokine ligand 8 Homo sapiens 56-59 8846658-1 1995 Sodium Fluoride (NaF) is the only medication so far clinically available with a bone formation stimulating property, through its peculiar mitogenic dose-dependent action on the osteoblast cell line. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 11540313-4 1995 A new treatment program entailing intermittent slow release sodium fluoride (SR-NaF) with continuous calcium citrate may capture desirable qualities of fluoride without toxic effects, and be therapeutically efficacious in postmenopausal osteoporosis. Sodium Fluoride 60-75 C-X-C motif chemokine ligand 8 Homo sapiens 80-83 7740640-1 1995 In order to evaluate the effect of sodium fluoride (NaF) on bone biomechanical competence, iliac crest biopsies were taken before and after one year of treatment in 12 osteoporotic patients, and before and after five years of treatment in 14 patients. Sodium Fluoride 35-50 C-X-C motif chemokine ligand 8 Homo sapiens 52-55 7853361-4 1994 Sodium fluoride (NaF), the most effective protectant against phosphorylation and aging, and the quaternary ammonium compounds reduced significantly AChE inhibition by DFP and paraoxon, to similar degrees. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 7960166-2 1994 The objective was to compare the effect of four dose levels of sodium monofluorophosphate (SMFP) and a single dose level of sodium fluoride (NaF) on DMFS, DMFT, and DFS Interproximal indices. Sodium Fluoride 124-139 C-X-C motif chemokine ligand 8 Homo sapiens 141-144 8166094-2 1994 and a 0.05% sodium fluoride (NaF) rinse would significantly reduce decalcification when compared with manual toothbrushing only (control group) or manual toothbrushing and daily use of a NaF rinse (rinse group). Sodium Fluoride 12-27 C-X-C motif chemokine ligand 8 Homo sapiens 29-32 8166094-2 1994 and a 0.05% sodium fluoride (NaF) rinse would significantly reduce decalcification when compared with manual toothbrushing only (control group) or manual toothbrushing and daily use of a NaF rinse (rinse group). Sodium Fluoride 12-27 C-X-C motif chemokine ligand 8 Homo sapiens 187-190 8162169-1 1994 The cellular effects of sodium fluoride (NaF) on human bone cells in vitro have been variable and dependent on the culture system used. Sodium Fluoride 24-39 C-X-C motif chemokine ligand 8 Homo sapiens 41-44 8032126-2 1994 Sodium fluoride (NaF) did not affect the extracellular pH of sperm, except that a slight acidification was caused by the 250 mM dose only. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 8304046-1 1993 In this study we tested the effects of sodium fluoride (NaF) in serum-free cultures of human marrow stromal osteoblast-like [hMS(OB)] cells. Sodium Fluoride 39-54 C-X-C motif chemokine ligand 8 Homo sapiens 56-59 7488352-1 1993 The 10 pivotal caries clinical studies employed in a recent meta-analysis to compare the anticaries efficacy of sodium fluoride (NaF) and sodium monofluorophosphate (MFP) dentifrices were subjected to a critical review. Sodium Fluoride 112-127 C-X-C motif chemokine ligand 8 Homo sapiens 129-132 7488354-1 1993 The comparison of the anticaries efficacy of dentifrices containing sodium fluoride (NaF) and sodium monofluorophosphate (SMFP) has recently been addressed through a meta-analysis of published head-to-head clinical trials. Sodium Fluoride 68-83 C-X-C motif chemokine ligand 8 Homo sapiens 85-88 8385495-1 1993 Sodium fluoride (NaF) alone below the concentration of 10 mM had no effect on platelet intracellular Ca2+ ([Ca2+]i). Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 8381770-8 1993 Inhibitory effects were obtained when GTP-binding protein functions were stimulated with sodium fluoride (NaF). Sodium Fluoride 89-104 C-X-C motif chemokine ligand 8 Homo sapiens 106-109 7679201-1 1993 Conflicting evidence has been reported concerning the mutagenicity of sodium fluoride (NaF), especially clastogenicity at concentrations of more than 1 mM. Sodium Fluoride 70-85 C-X-C motif chemokine ligand 8 Homo sapiens 87-90 8427047-1 1993 The anabolic effects of sodium fluoride (NaF) on trabecular bone mass in osteoporosis is now well established. Sodium Fluoride 24-39 C-X-C motif chemokine ligand 8 Homo sapiens 41-44 8461565-1 1993 The future of sodium fluoride (NaF), the most potent osteoblast stimulator known to man, is in the balance. Sodium Fluoride 14-29 C-X-C motif chemokine ligand 8 Homo sapiens 31-34 21043600-3 1993 Phorbol myristate acetate (PMA; a PKC activator), sodium fluoride (NaF; a putative G protein activator), ADP and collagen stimulated the uptake of [(45)Ca(2+)] by platelets in dose-dependent manners. Sodium Fluoride 50-65 C-X-C motif chemokine ligand 8 Homo sapiens 67-70 1422951-1 1992 Clinical studies on the use of sodium fluoride (NaF) in osteoporotic patients have demonstrated increased spinal bone mass without a reduction in vertebral fracture incidence, and a trend towards reduced appendicular bone mass with an increase in peripheral fracture incidence. Sodium Fluoride 31-46 C-X-C motif chemokine ligand 8 Homo sapiens 48-51 1597151-5 1992 Sodium fluoride (NaF)-stimulated IP accumulation was also inhibited by U-73122 (from 1539 +/- 132 dpm to 414 +/- 21 dpm) while LH release increased from 22.9 +/- 1.4% total cellular LH to 28.0 +/- 2.2%. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 1540395-2 1992 Phorbol 12-myristate 13-acetate (PMA), alpha-thrombin, and sodium fluoride (NaF), a direct G-protein activator, produced a rapid and time-dependent translocation of PKC from the cytosol to the membrane. Sodium Fluoride 59-74 C-X-C motif chemokine ligand 8 Homo sapiens 76-79 1617494-2 1992 As the bioavailability of sodium fluoride (NaF) can be impaired by concomitant absorption of calcium, both drugs have to be ingested separately. Sodium Fluoride 26-41 C-X-C motif chemokine ligand 8 Homo sapiens 43-46 1425895-1 1992 Sodium fluoride (NaF) is used in the treatment of axial osteoporosis and so is mostly given to old patients. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 1537591-3 1992 Co-incubation of neutrophils with neomycin and the direct G-protein activator sodium fluoride (NaF) resulted in an enhanced leukotriene formation at 0.5 mM neomycin and an inhibition at a concentration of 10 mM. Sodium Fluoride 78-93 C-X-C motif chemokine ligand 8 Homo sapiens 95-98 1492198-3 1992 The mentioned fact supported authors to study the impact of short-term 24 hrs sodium fluoride (NaF) action in concentration range of 0-500 mg.1(-1) drinking water in the frame of so-called minimal testing set (analysis of chromosomal aberrations in human peripheral lymphocytes, Ames test). Sodium Fluoride 78-93 C-X-C motif chemokine ligand 8 Homo sapiens 95-98 1660854-2 1991 Similar data were observed for the direct G-protein activator sodium fluoride (NaF). Sodium Fluoride 62-77 C-X-C motif chemokine ligand 8 Homo sapiens 79-82 1930284-7 1991 Analysis of inhibition kinetics further showed that (a) the reversible inhibition of both ComEst and MonEst by sodium fluoride (NaF) was noncompetitive (with Ki values of 1.28 and 0.01 mM, respectively, indicating a marked difference in sensitivity); (b) the inhibition of MonEst by PMSF was of "mixed" noncompetitive-competitive type; and (c) that DEPC exerted noncompetitive inhibition with similar Ki values (0.05 mM) for both esterase species. Sodium Fluoride 111-126 C-X-C motif chemokine ligand 8 Homo sapiens 128-131 1922513-2 1991 When blood was preserved in microtest tubes coated with sodium fluoride (NaF) and measured after 1 hour at room temperature, the glucose level decreased by 7 to 36%. Sodium Fluoride 56-71 C-X-C motif chemokine ligand 8 Homo sapiens 73-76 1654060-2 1991 We report that sodium fluoride (NaF), a potent activator of cellular guanine nucleotide-binding proteins, affected time- and concentration-dependent generation of prostacyclin (PGI2) by cultured human umbilical vein endothelial cells without evidence of cellular toxicity detected by 51Cr or lactate dehydrogenase release. Sodium Fluoride 15-30 C-X-C motif chemokine ligand 8 Homo sapiens 32-35 1901832-4 1991 The combined incubation of platelets with PCB and sodium fluoride (NaF), an activator of G-proteins, resulted in synergistic 12-HETE generation compared to stimulation with NaF or PCB alone. Sodium Fluoride 50-65 C-X-C motif chemokine ligand 8 Homo sapiens 67-70 1901832-4 1991 The combined incubation of platelets with PCB and sodium fluoride (NaF), an activator of G-proteins, resulted in synergistic 12-HETE generation compared to stimulation with NaF or PCB alone. Sodium Fluoride 50-65 C-X-C motif chemokine ligand 8 Homo sapiens 173-176 1790390-1 1991 Fifty-two postmenopausal women (mean age 60 +/- 5 years) with low BMD (less than -2SD of young adult values) but who had not experienced previous crush fracture were treated with 50 mg of sodium fluoride (NaF), 1 g of calcium and 400 IU of vitamin D2 per day for 2 years. Sodium Fluoride 188-203 C-X-C motif chemokine ligand 8 Homo sapiens 205-208 1937907-1 1991 Simultaneous stimulation of human neutrophils (PMN) with the receptor-mediated activator formyl-met-leu-phe (FMLP) and the G protein activator sodium fluoride (NaF) resulted in the synergistic generation of leukotrienes. Sodium Fluoride 143-158 C-X-C motif chemokine ligand 8 Homo sapiens 160-163 27467661-4 1991 Included among these is a distinct isoenzyme (group), defined by IEF with acidic isoelectric points (pI) of approximately 6.0, that is characterized by its strong staining intensity and inhibition by sodium fluoride (NaF). Sodium Fluoride 200-215 C-X-C motif chemokine ligand 8 Homo sapiens 217-220 2096385-1 1990 Cytotoxicity of sodium fluoride (NaF) on human diploid cells in exponential growth was investigated using a) Flow 1000 cells, passage No. Sodium Fluoride 16-31 C-X-C motif chemokine ligand 8 Homo sapiens 33-36 2110856-1 1990 The oral administration of sodium fluoride (NaF) (40 mumol/100 body weight [bw]) to fasting rats produced an immediate fall in insulin levels and the consequent increase in glycemia. Sodium Fluoride 27-42 C-X-C motif chemokine ligand 8 Homo sapiens 44-47 2328269-2 1990 Basal and forskolin-stimulated adenylate cyclase activity were significantly lower in the PTSD group whereas aluminum chloride plus sodium fluoride (AlCl3/NaF)- and prostaglandin E1 (PGE1)-stimulated responses were normal. Sodium Fluoride 132-147 C-X-C motif chemokine ligand 8 Homo sapiens 155-158 2339639-1 1990 To assess whether an interval of a few hours would be advisable between an intake of sodium fluoride (NaF) and that of calcium salts when treating osteoporotic patients with vertebral collapse, we carried out three pharmacokinetic studies in 12 healthy fasting volunteer subjects to compare the fluoride bioavailability provided by NaF alone and NaF combined with two calcium salts. Sodium Fluoride 85-100 C-X-C motif chemokine ligand 8 Homo sapiens 102-105 2339640-1 1990 The gastrointestinal absorption of enteric-coated (EC) tablets of sodium fluoride (NaF) with respect to different time schedules of administration of calcium supplements in solution was tested. Sodium Fluoride 66-81 C-X-C motif chemokine ligand 8 Homo sapiens 83-86 2105325-5 1990 Sodium fluoride (NaF), at concentrations known to activate guanine nucleotide regulatory proteins (G proteins), directly stimulated HUVEC PGI2 synthesis in a dose-dependent and time-dependent manner (20 mM NaF, 4.4 +/- 0.5-fold increase at 10 min, 11.9 +/- 1.5-fold increase at 30 min). Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 2105325-5 1990 Sodium fluoride (NaF), at concentrations known to activate guanine nucleotide regulatory proteins (G proteins), directly stimulated HUVEC PGI2 synthesis in a dose-dependent and time-dependent manner (20 mM NaF, 4.4 +/- 0.5-fold increase at 10 min, 11.9 +/- 1.5-fold increase at 30 min). Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 206-209 1688564-9 1990 Further, dose-response studies showed that sodium fluoride (NaF), activator of G-binding proteins, and ouabain, inhibitor of Na+/H+ pump, increased levels of IL-6 mRNA. Sodium Fluoride 43-58 C-X-C motif chemokine ligand 8 Homo sapiens 60-63 2402188-1 1990 In isolated guinea pig gastric chief cells, sodium fluoride (NaF) stimulated a monophasic increase in diacylglycerol accumulation, while cholecystokinin (CCK) strongly stimulated its biphasic accumulation. Sodium Fluoride 44-59 C-X-C motif chemokine ligand 8 Homo sapiens 61-64 34781073-2 2022 DESIGN: Ameloblast-like cells (LS8 cells) were exposed to various concentrations of sodium fluoride (NaF) for up to 48 h. Runx2 expression was downregulated by gene silencing, and Foxo1 expression was up- and downregulated by gene overexpression and silencing, respectively. Sodium Fluoride 84-99 C-X-C motif chemokine ligand 8 Homo sapiens 101-104 34763226-3 2022 At present, the objective of this study was to investigate the relationship between down-regulation of IKBKG gene expression and hepatocyte senescence induced by sodium fluoride (NaF). Sodium Fluoride 162-177 C-X-C motif chemokine ligand 8 Homo sapiens 179-182 34878076-1 2021 This randomized three-armed controlled clinical trial compared the effect of titanium tetrafluoride (TiF4) and sodium fluoride (NaF) varnishes on caries control in smooth surfaces of permanent dentition and children"s acceptability. Sodium Fluoride 111-126 C-X-C motif chemokine ligand 8 Homo sapiens 128-131 34941643-1 2021 This report describes the significance of the kinetic parameters (k-values) obtained from the analysis of dynamic positron emission tomography (PET) scans using the Hawkins model describing the pharmacokinetics of sodium fluoride ((18F)NaF) to understand bone physiology. Sodium Fluoride 214-229 C-X-C motif chemokine ligand 8 Homo sapiens 236-239 34816902-2 2021 This study aimed to compare the effects of conventional (sodium fluoride (NaF)) and stannous fluoride (SnF2)-containing dentifrices on reducing erosive tooth wear (ETW). Sodium Fluoride 57-72 C-X-C motif chemokine ligand 8 Homo sapiens 74-77 34601318-1 2021 OBJECTIVE: Sodium fluoride (NaF) plays an important role in preventing dental caries. Sodium Fluoride 11-26 C-X-C motif chemokine ligand 8 Homo sapiens 28-31 34601834-11 2021 CONCLUSION: Sodium fluoride (NaF) should be used as preservative to avoid ethanol neo-genesis during storage and transportation of blood samples for alcohol analysis. Sodium Fluoride 12-27 C-X-C motif chemokine ligand 8 Homo sapiens 29-32 34151709-6 2021 We showed that sodium fluoride (NaF) reduces cell viability in a concentration-dependent manner (p < 0.05) up to a 96-h time-point when compared to control. Sodium Fluoride 15-30 C-X-C motif chemokine ligand 8 Homo sapiens 32-35 34080770-6 2021 Further, we verified that sodium fluoride (NaF) decreases miR-486-3p expression in human osteoblasts and overexpression of miR-486-3p reduces fluoride-induced osteoblast proliferation and activation. Sodium Fluoride 26-41 C-X-C motif chemokine ligand 8 Homo sapiens 43-46 34348775-1 2021 BACKGROUND: Silver diamine fluoride (SDF) and sodium fluoride (NaF) are widely used for caries management. Sodium Fluoride 46-61 C-X-C motif chemokine ligand 8 Homo sapiens 63-66 34787252-2 2021 The specimens were exposed to mesoporous silica (MS) nanocomposites containing fluoride by association with titanium tetrafluoride (TiF4) or sodium fluoride (NaF). Sodium Fluoride 141-156 C-X-C motif chemokine ligand 8 Homo sapiens 158-161 34082514-0 2021 Incidental Skeletal Findings on Sodium-fluoride Positron Emission Tomography: A Collection of Benign Tumors Sodium-fluoride (NaF) positron emission tomography (PET) is a sensitive method to detect altered bone mineralization. Sodium Fluoride 32-47 C-X-C motif chemokine ligand 8 Homo sapiens 125-128 34082514-0 2021 Incidental Skeletal Findings on Sodium-fluoride Positron Emission Tomography: A Collection of Benign Tumors Sodium-fluoride (NaF) positron emission tomography (PET) is a sensitive method to detect altered bone mineralization. Sodium Fluoride 108-123 C-X-C motif chemokine ligand 8 Homo sapiens 125-128 35537534-1 2022 OBJECTIVE: Aiming to achieve improved antibacterial performance for dental application, sodium fluoride (NaF) nanoparticles and photopolymerizable N,N-dodecylvinylimidazole (DCV) were co-introduced into resin adhesives at different ratios. Sodium Fluoride 88-103 C-X-C motif chemokine ligand 8 Homo sapiens 105-108 35589431-1 2022 AIM: To investigate if the pattern of fluorine-18-labelled sodium fluoride (18F-NaF) uptake on integrated positron-emission tomography (PET)/magnetic resonance imaging (MRI) of bone marrow lesions (BML) and osteophytes differs between different knee compartments. Sodium Fluoride 59-74 C-X-C motif chemokine ligand 8 Homo sapiens 80-83 35570014-1 2022 OBJECTIVES: The objectives of this study were to compare the amount of fluoride delivered via a topical application of 38% silver diamine fluoride (SDF) solution and 5% sodium fluoride (NaF) varnish as well as to determine the amount of 38% SDF solution delivered using various micro-applicators. Sodium Fluoride 169-184 C-X-C motif chemokine ligand 8 Homo sapiens 186-189 35421827-3 2022 Using Sprague-Dawley rats exposed to sodium fluoride (NaF) from gestation through delivery until the neonatal offspring reached six months of age as an in vivo model. Sodium Fluoride 37-52 C-X-C motif chemokine ligand 8 Homo sapiens 54-57 35219459-2 2022 OBJECTIVE: This systematic review and meta-analyses aimed to evaluate the potential protective effect of titanium tetrafluoride (TiF4) compound compared to sodium fluoride (NaF) on eroded enamel or dentin. Sodium Fluoride 156-171 C-X-C motif chemokine ligand 8 Homo sapiens 173-176 35226681-1 2022 INTRODUCTION: Sodium fluoride (NaF) tubes are the recommended tubes for glucose measurements, but these are expensive, have limited number of uses, and are not always available in low resource settings. Sodium Fluoride 14-29 C-X-C motif chemokine ligand 8 Homo sapiens 31-34 35168236-1 2022 This study evaluated the combination of a sugarcane cystatin (CaneCPI-5) and sodium fluoride (NaF) in acquired pellicle engineering for the prevention of dental erosion in vitro. Sodium Fluoride 77-92 C-X-C motif chemokine ligand 8 Homo sapiens 94-97 35055148-0 2022 Biphasic Functions of Sodium Fluoride (NaF) in Soft and in Hard Periodontal Tissues. Sodium Fluoride 22-37 C-X-C motif chemokine ligand 8 Homo sapiens 39-42 35055148-1 2022 Sodium fluoride (NaF) is widely used in clinical dentistry. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 35096851-1 2021 The aim of the study was to assess the quality and reproducibility of reducing the injected (18F) sodium fluoride ((18F)NaF) dose while maintaining diagnostic imaging quality in bone imaging in a preclinical skeletal model using digital photon counting PET (dPET) detector technology. Sodium Fluoride 98-113 C-X-C motif chemokine ligand 8 Homo sapiens 120-123 35021171-3 2022 This study compares the efficacy of a PB mouthrinse with 0.12% chlorhexidine (CHX) and 0.05% sodium fluoride (NaF) mouthrinse on the colony counts of mutans streptococci (MS) in children. Sodium Fluoride 93-108 C-X-C motif chemokine ligand 8 Homo sapiens 110-113 2549106-1 1989 This report reviews the methods and findings of published clinical studies comparing dentifrices containing sodium fluoride (NaF) and sodium monofluorophosphate (Na2PO3F) for the purpose of determining whether sodium fluoride formulations have superior cariostatic effects. Sodium Fluoride 108-123 C-X-C motif chemokine ligand 8 Homo sapiens 125-128 2768695-1 1989 This study determined the effect of brushing with 0.4% stannous fluoride (SnF2) or 0.22% sodium fluoride (NaF) on clinical and microbial parameters associated with gingivitis. Sodium Fluoride 89-104 C-X-C motif chemokine ligand 8 Homo sapiens 106-109 2668365-1 1989 A three-year clinical trial was conducted to determine whether a sodium fluoride (NaF) dentifrice had greater cariostatic effects than a sodium monofluorophosphate (Na2PO3F) dentifrice. Sodium Fluoride 65-80 C-X-C motif chemokine ligand 8 Homo sapiens 82-85 2790854-1 1989 Specimens of human dental enamel were topically applied with solutions of sodium fluoride (NaF) or acidulated phosphate fluoride (APF) before and after laser irradiation. Sodium Fluoride 74-89 C-X-C motif chemokine ligand 8 Homo sapiens 91-94 3165239-7 1988 Daily fluoride mouth rinsing with a 0.2% solution sodium fluoride (NaF) retarded lesion development significantly, whereas the fluoride solution with low pH inhibited lesion formation completely. Sodium Fluoride 50-65 C-X-C motif chemokine ligand 8 Homo sapiens 67-70 3348776-1 1988 The ability of sodium fluoride (NaF) and thrombin to stimulate aggregation and protein phosphorylation in intact human platelets was measured and compared. Sodium Fluoride 15-30 C-X-C motif chemokine ligand 8 Homo sapiens 32-35 3126375-1 1988 The sensitivity of fibroblasts (L cells) to low concentrations of sodium fluoride (NaF) was examined using the same cell during a series of stimuli. Sodium Fluoride 66-81 C-X-C motif chemokine ligand 8 Homo sapiens 83-86 10872408-1 1987 The purpose of this investigation was to examine the potential genotoxic influence of sodium fluoride (NaF) on mammalian cells by means of a mouse bone-marrow micronucleus test. Sodium Fluoride 86-101 C-X-C motif chemokine ligand 8 Homo sapiens 103-106 3114629-3 1987 Sodium fluoride (NaF) has previously been shown to be clastogenic in vitro in Syrian hamster cells and human fibroblasts. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 3111669-1 1987 Daily treatment with 30 mg of sodium fluoride (NaF) and 1 g of calcium over a 3-year period increased the bone mineral content (BMC) in the spines of women (n = 25) with osteoporosis. Sodium Fluoride 30-45 C-X-C motif chemokine ligand 8 Homo sapiens 47-50 3762571-1 1986 Sodium fluoride (NaF) was assayed for the induction of DNA-repair synthesis in WI-38 human diploid fibroblasts and in primary cultures of rat hepatocytes. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 3028102-0 1986 On the role of guanine nucleotide binding regulatory proteins (G-proteins) in signal transduction in human platelets: studies with sodium fluoride (NaF). Sodium Fluoride 131-146 C-X-C motif chemokine ligand 8 Homo sapiens 148-151 3768198-1 1986 The benefit of sodium fluoride (NaF) in the therapy of osteoporosis is still controversial. Sodium Fluoride 15-30 C-X-C motif chemokine ligand 8 Homo sapiens 32-35 3768209-1 1986 Sodium fluoride (NaF) is the single most effective agent for increasing bone volume in the osteoporotic skeleton. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 3457629-3 1986 A carboxylic esterase isoenzyme which can be inhibited completely and selectively by sodium fluoride (NaF) was demonstrated by isoelectric focusing on horizontal polyacrylamide gels. Sodium Fluoride 85-100 C-X-C motif chemokine ligand 8 Homo sapiens 102-105 3868620-3 1985 One isoenzyme consisting of one or two components (bands) could be completely and selectively inhibited by addition of 40 mM sodium fluoride (NaF) to the staining bath. Sodium Fluoride 125-140 C-X-C motif chemokine ligand 8 Homo sapiens 142-145 6738571-1 1984 The effect of treatment of cultured human oral keratinocytes with sodium fluoride (NaF) has been investigated with respect to induction of unscheduled DNA synthesis (UDS). Sodium Fluoride 66-81 C-X-C motif chemokine ligand 8 Homo sapiens 83-86 6230119-4 1984 Inhibition studies of cytochemical ANAE activity with sodium fluoride (NaF) show that the presence of NaF-sensitive or NaF-resistant ANAE enzymes is often unrelated to the diagnostic category of acute leukemia. Sodium Fluoride 54-69 C-X-C motif chemokine ligand 8 Homo sapiens 71-74 6230119-4 1984 Inhibition studies of cytochemical ANAE activity with sodium fluoride (NaF) show that the presence of NaF-sensitive or NaF-resistant ANAE enzymes is often unrelated to the diagnostic category of acute leukemia. Sodium Fluoride 54-69 C-X-C motif chemokine ligand 8 Homo sapiens 102-105 6230119-4 1984 Inhibition studies of cytochemical ANAE activity with sodium fluoride (NaF) show that the presence of NaF-sensitive or NaF-resistant ANAE enzymes is often unrelated to the diagnostic category of acute leukemia. Sodium Fluoride 54-69 C-X-C motif chemokine ligand 8 Homo sapiens 102-105 7207691-0 1981 A subacute fluoride intoxication during treatment of osteoporosis with sodium fluoride (NaF): case report. Sodium Fluoride 71-86 C-X-C motif chemokine ligand 8 Homo sapiens 88-91 7204643-2 1980 To test for the possible origin of these labeled cells from monocytes, we examined them for the presence of sodium fluoride- (NaF) sensitive non-specific esterase (NSE), an enzyme characteristic of monocytes. Sodium Fluoride 108-123 C-X-C motif chemokine ligand 8 Homo sapiens 126-129 6103847-3 1980 The present study analyzes the effects of heparin and sodium fluoride (NaF) on these changes. Sodium Fluoride 54-69 C-X-C motif chemokine ligand 8 Homo sapiens 71-74 6938993-1 1980 Three types of sustained and controlled release dosage forms of sodium fluoride (NaF) for the prevention of dental caries are reviewed. Sodium Fluoride 64-79 C-X-C motif chemokine ligand 8 Homo sapiens 81-84 759278-1 1979 The bioavailability of Ossin, a drug for the treatment of osteoporosis, containing 40 mg of NaF, was investigated. Sodium Fluoride 23-28 C-X-C motif chemokine ligand 8 Homo sapiens 92-95 580872-1 1978 Thyrotropin (TSH)- and sodium fluoride (NaF)-sensitive adenylate cyclase (AC) activity was measured in ten cases of "cold" thyroid nodules and compared with perinodular tissue. Sodium Fluoride 23-38 C-X-C motif chemokine ligand 8 Homo sapiens 40-43 207727-2 1978 The present study examined PMN CL in the absence of phagocytosis using sodium fluoride (NaF), a nonparticulate agent and known stimulator of cellular oxidative metabolism. Sodium Fluoride 71-86 C-X-C motif chemokine ligand 8 Homo sapiens 88-91 199608-2 1977 Two relatively specific inhibitors of glycolysis (iodoacetate [IA], and sodium fluoride [NaF]) and a sulfhydryl-binding agent (N-ethylmaleimide [NEM] markedly inhibited phagocytosis and reduced cell deformability. Sodium Fluoride 72-87 C-X-C motif chemokine ligand 8 Homo sapiens 89-92 5982419-0 1966 [Behavior of calcemia, phosphoremia, calciuria, phosphaturia and alkaline phosphatase in normal subjects treated with sodium fluoride (NaF)]. Sodium Fluoride 118-133 C-X-C motif chemokine ligand 8 Homo sapiens 135-138 33857626-2 2021 Although induction of death receptor-initiated extrinsic apoptosis by sodium fluoride (NaF) has been reported, its mechanism of action is still not clearly defined. Sodium Fluoride 70-85 C-X-C motif chemokine ligand 8 Homo sapiens 87-90 33711406-1 2021 OBJECTIVE: To examine the biochemical components of multi-species biofilm on the arginine (Arg)-sodium fluoride (NaF) varnish-treated enamel following bacterial pH-cycling. Sodium Fluoride 96-111 C-X-C motif chemokine ligand 8 Homo sapiens 113-116 33893805-5 2022 To one of the aliquots sodium fluoride (NaF, 1% w/v) was added. Sodium Fluoride 23-38 C-X-C motif chemokine ligand 8 Homo sapiens 40-43 33116000-1 2021 The aim of this study was to investigate the effects of potassium fluoride (KF) and sodium fluoride (NaF) in different concentrations on micro-shear bond strength (microSBS) and their protective effects against acid. Sodium Fluoride 84-99 C-X-C motif chemokine ligand 8 Homo sapiens 101-104 33738852-3 2021 The objective of the present study was to investigate the protective effects of glycine on sodium fluoride (NaF) exposure and the possible underlying mechanisms in a porcine testicular Sertoli cell line model. Sodium Fluoride 91-106 C-X-C motif chemokine ligand 8 Homo sapiens 108-111 32789453-1 2021 OBJECTIVE: Sodium fluoride (NaF) has been applied to inhibit glycolysis in venous specimens for decades. Sodium Fluoride 11-26 C-X-C motif chemokine ligand 8 Homo sapiens 28-31 33646017-1 2021 Background: Patients with osteoblastic bone metastases are candidates for radium-223 (223RaCl2) therapy and may undergo sodium fluoride-18 (18F-NaF) positron emission tomography-computed tomography imaging to identify bone lesions. Sodium Fluoride 120-135 C-X-C motif chemokine ligand 8 Homo sapiens 144-147 33227158-1 2021 Historically, blood alcohol concentration (BAC) studies utilized a 1% concentration of the preservative sodium fluoride (NaF), leaving an information gap supporting usage of lower concentrations of NaF to preserve ethanol. Sodium Fluoride 104-119 C-X-C motif chemokine ligand 8 Homo sapiens 121-124 33396131-6 2021 This study aimed to determine the effect of sodium fluoride (NaF) on human RBC under in vitro conditions. Sodium Fluoride 44-59 C-X-C motif chemokine ligand 8 Homo sapiens 61-64 33384825-2 2021 The purpose of this study was to evaluate the surface changes of resin-modified glass ionomer (RMGI) when immersed in a sodium fluoride (NaF) solution according to pH and time. Sodium Fluoride 120-135 C-X-C motif chemokine ligand 8 Homo sapiens 137-140 33885393-5 2021 Aim: This study aimed to evaluate the clinical effectiveness of biannual application of 38% SDF followed by 5% sodium fluoride (NaF) varnish for arresting dental caries in children and its parental acceptance. Sodium Fluoride 111-126 C-X-C motif chemokine ligand 8 Homo sapiens 128-131 33339152-1 2020 The in vitro study objectives were to investigate the effect of arginine (Arg) incorporation in a 5% sodium fluoride (NaF) varnish on its physical and chemical properties including F/Arg release. Sodium Fluoride 101-116 C-X-C motif chemokine ligand 8 Homo sapiens 118-121 33057826-7 2020 RESULTS: In terms of WSL prevention, sodium fluoride (NaF) varnish had the highest cumulative ranking for the short-term decalcification index (99.3%); acidulated phosphate fluoride (APF) foam ranked first for long-term incidence (96.9%), followed by difluorosilane (Dfs) varnish and high-concentration fluoride toothpaste (HFT) (79.4% and 77.4%, respectively). Sodium Fluoride 37-52 C-X-C motif chemokine ligand 8 Homo sapiens 54-57 33157159-1 2020 OBJECTIVES: To investigate the remineralising and staining effects of sodium fluoride (NaF) with silver nanoparticles (AgNPs) on artificial dentine caries. Sodium Fluoride 70-85 C-X-C motif chemokine ligand 8 Homo sapiens 87-90 32731110-17 2020 Subsequently, in human osteoblasts treated with sodium fluoride (NaF), the results also showed that NaF caused low expression of miR-4755-5p and increased expression of Cyclin D1. Sodium Fluoride 48-63 C-X-C motif chemokine ligand 8 Homo sapiens 65-68 32731110-17 2020 Subsequently, in human osteoblasts treated with sodium fluoride (NaF), the results also showed that NaF caused low expression of miR-4755-5p and increased expression of Cyclin D1. Sodium Fluoride 48-63 C-X-C motif chemokine ligand 8 Homo sapiens 100-103 32246208-1 2020 AIM: To compare the effects of high-dose therapy (HDT consisting of high-dose chemotherapy followed by autologous stem cell transplantation) and conventional-dose chemotherapy (non-HDT) on the uptake of 18F-sodium fluoride (NaF) in the whole bone, pelvis, and femoral neck of multiple myeloma (MM) patients. Sodium Fluoride 207-222 C-X-C motif chemokine ligand 8 Homo sapiens 224-227 33139990-1 2020 Background: The present study aimed to investigate whether dual-phase F-18 sodium-fluoride (NaF) positron emission tomography/computed tomography (PET/CT) could improve the diagnostic accuracy of detecting bone metastasis in cancer patients with a solitary bone lesion compared to conventional F-18 NaF PET/CT. Sodium Fluoride 75-90 C-X-C motif chemokine ligand 8 Homo sapiens 92-95 33139990-1 2020 Background: The present study aimed to investigate whether dual-phase F-18 sodium-fluoride (NaF) positron emission tomography/computed tomography (PET/CT) could improve the diagnostic accuracy of detecting bone metastasis in cancer patients with a solitary bone lesion compared to conventional F-18 NaF PET/CT. Sodium Fluoride 75-90 C-X-C motif chemokine ligand 8 Homo sapiens 299-302 31804143-1 2020 Positron emission tomography (PET) with 18F-Sodium fluoride (18F-NaF) has emerged as a promising non-invasive imaging modality to identify high-risk and ruptured atherosclerotic plaques. Sodium Fluoride 40-59 C-X-C motif chemokine ligand 8 Homo sapiens 65-68 32299619-1 2020 AIM: To analyse the relationship between 18F-labelled sodium fluoride (NaF) uptake and lumbar back pain in patients with lumbosacral transitional vertebra (LSTV) a congenital malformation of the lumbosacral spine. Sodium Fluoride 54-69 C-X-C motif chemokine ligand 8 Homo sapiens 71-74 32428523-1 2020 OBJECTIVES: The study aimed to compare the effectiveness of 38% silver diamine fluoride (SDF) solution, and 5% sodium fluoride (NaF) varnish applied semiannually in arresting dentin caries in young children with high caries risk. Sodium Fluoride 111-126 C-X-C motif chemokine ligand 8 Homo sapiens 128-131 31667675-2 2020 We sought to address this limitation by utilizing the distinctively high bone uptake rate constant Ki expected from 18F-Sodium Fluoride (18F-NaF) to segment bones from PET data and support 5-class hybrid PET/MR-driven AC for 18F-NaF and 18F-Fluorodeoxyglucose (18F-FDG) PET/MR cardiovascular imaging. Sodium Fluoride 116-135 C-X-C motif chemokine ligand 8 Homo sapiens 141-144 31734781-1 2020 AIMS: To investigate the benefit of utilizing 18F-sodium fluoride (NaF) PET/CT over calcium and Framingham scoring for potential preventative coronary artery disease (CAD) intervention. Sodium Fluoride 46-65 C-X-C motif chemokine ligand 8 Homo sapiens 67-70 31786626-6 2020 18F-fluorodeoxyglucose (FDG) (49/53) and 18F-sodium fluoride (NaF) (5/53) were the most utilized tracers to visualize carotid wall inflammation and microcalcification, respectively. Sodium Fluoride 41-60 C-X-C motif chemokine ligand 8 Homo sapiens 62-65 31629684-1 2020 PURPOSE: This study aimed to elucidate the effects of hydrogen peroxide (H2O2) and sodium fluoride (NaF) on titanium surfaces under conditions mimicking those encountered during dental treatment. Sodium Fluoride 83-98 C-X-C motif chemokine ligand 8 Homo sapiens 100-103 31773235-1 2020 PURPOSE: We examined the literature to elucidate the role of 18F-sodium fluoride (NaF)-PET in atherosclerosis. Sodium Fluoride 61-80 C-X-C motif chemokine ligand 8 Homo sapiens 82-85 32456181-2 2020 Sodium fluoride (18F-NaF) is a highly sensitive tracer of bone reconstruction, evolving as an important imaging agent for the assessment of malignant bone diseases. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 21-24 32440119-1 2020 Objectives: The first objective of this study was to prepare sodium fluoride (NaF) solution with various concentrations of polyethylene glycol-coated silver nanoparticles (PEG-AgNPs). Sodium Fluoride 61-76 C-X-C motif chemokine ligand 8 Homo sapiens 78-81 32142400-11 2020 Among the reviewed self-applied topical fluoride methods, daily use of a 0.2% sodium fluoride (NaF) mouth rinse is most likely to be the most effective, followed by 1100 ppm to 1500 ppm fluoride toothpaste plus 0.05% NaF mouth rinse, and 1100 ppm to 1500 ppm fluoride toothpaste. Sodium Fluoride 78-93 C-X-C motif chemokine ligand 8 Homo sapiens 95-98 32368057-1 2020 Objective: To investigate the remineralizing and staining effects of sodium fluoride (NaF) solution with polyethylene glycol-coated silver nanoparticles (PEG-AgNPs) on artificial dentine caries. Sodium Fluoride 69-84 C-X-C motif chemokine ligand 8 Homo sapiens 86-89 29948889-1 2020 We investigated the impact of reconstruction parameters and cardiac motion-correction in 18F Sodium Fluoride (18F-NaF) PET. Sodium Fluoride 93-108 C-X-C motif chemokine ligand 8 Homo sapiens 114-117 32308752-9 2020 Results: Both in vivo and in vitro experiments showed that sodium fluoride (NaF) caused mitochondrial dysfunction and impaired mitochondrial biogenesis. Sodium Fluoride 59-74 C-X-C motif chemokine ligand 8 Homo sapiens 76-79 31811067-4 2020 Though 18F-sodium fluoride (18F-NaF) was one of the oldest medical tracers but was replaced by other tracers until recently, owing to its physical properties. Sodium Fluoride 7-26 C-X-C motif chemokine ligand 8 Homo sapiens 32-35 33005593-3 2020 Here, we investigated whether sodium fluoride (NaF) has the ability to induce DNA damage and chromosomal abnormalities in human osteosarcoma cells after 48 and 72 h of exposure. Sodium Fluoride 30-45 C-X-C motif chemokine ligand 8 Homo sapiens 47-50 32079388-6 2020 Sodium fluoride (NaF) PET/CT is a promising imaging modality in evaluation of skeletal system. Sodium Fluoride 0-15 C-X-C motif chemokine ligand 8 Homo sapiens 17-20 31860524-1 2020 OBJECTIVES: Atherosclerotic plaque molecular imaging with F-sodium fluoride (NaF) PET with computed tomography (PET-CT) may identify active unstable microcalcification. Sodium Fluoride 58-75 C-X-C motif chemokine ligand 8 Homo sapiens 77-80 31975332-1 2021 BACKGROUND: Microcalcifications cannot be identified with the present resolution of CT; however, 18F-sodium fluoride (18F-NaF) positron emission tomography (PET) imaging has been proposed for non-invasive identification of microcalcification. Sodium Fluoride 97-116 C-X-C motif chemokine ligand 8 Homo sapiens 122-125 33176315-1 2020 The aim of this study was to evaluate the protective effect of propylene glycol alginate (PGA) associated with sodium fluoride (NaF) against enamel erosion and erosion-abrasion. Sodium Fluoride 111-126 C-X-C motif chemokine ligand 8 Homo sapiens 128-131 31715382-2 2020 Diagnosis of bone metabolic activity is currently through integrating Positron Emission Tomography (PET) with Sodium Fluoride (18F-NaF) biomarkers. Sodium Fluoride 110-125 C-X-C motif chemokine ligand 8 Homo sapiens 131-134 31598775-4 2020 Various storage conditions, that is 4 C or room temperature (RT) and the addition of sodium fluoride (NaF), were compared during storage up to 30 days. Sodium Fluoride 86-101 C-X-C motif chemokine ligand 8 Homo sapiens 103-106 33223648-1 2020 Aim: The aim is to compare the effects of diode laser, GC tooth mousse, and sodium fluoride (NaF) varnish on dentinal hypersensitivity by scanning electron microscopic (SEM) evaluation. Sodium Fluoride 76-91 C-X-C motif chemokine ligand 8 Homo sapiens 93-96 32515426-1 2020 PURPOSE: To assess the effects of experimental titanium tetrafluoride (TiF4) varnish and commercial sodium fluoride (NaF) varnish with CO2 laser on enamel hardness. Sodium Fluoride 100-115 C-X-C motif chemokine ligand 8 Homo sapiens 117-120 31571042-2 2019 The present study aimed to evaluate the association between carotid 18F-sodium fluoride (NaF) and 18F-fluorodeoxyglucose (FDG) uptake with the severity of ischemic vascular brain disease on MRI in patients with carotid artery disease. Sodium Fluoride 68-87 C-X-C motif chemokine ligand 8 Homo sapiens 89-92 31424110-1 2019 This study characterized the distribution of [18 F]-sodium fluoride (NaF) uptake and blood flow in the femur and acetabulum in hip osteoarthritis (OA) patients to find associations between bone remodeling and cartilage composition in the presence of morphological abnormalities using simultaneous positron emission tomography and magnetic resonance imaging (PET/MR), quantitative magnetic resonance imaging (MRI) and femur shape modeling. Sodium Fluoride 52-67 C-X-C motif chemokine ligand 8 Homo sapiens 69-72 31741329-1 2021 BACKGROUND: Fluoride-18 sodium fluoride (18F-NaF) localizes in microcalcifications in atheroma. Sodium Fluoride 12-39 C-X-C motif chemokine ligand 8 Homo sapiens 45-48 31488175-1 2019 INTRODUCTION: In prostate cancer patients, imaging of bone metastases is enhanced through the use of sodium fluoride positron emission tomography (18F-NaF PET/CT). Sodium Fluoride 101-116 C-X-C motif chemokine ligand 8 Homo sapiens 151-154 30565018-2 2019 Accumulating evidence demonstrates that vitamin C administration ameliorate sodium fluoride (NaF)-induced oxidative stress. Sodium Fluoride 76-91 C-X-C motif chemokine ligand 8 Homo sapiens 93-96 30905242-1 2019 Objective: The objective of this study was to compare the remineralizing effect of sodium fluoride (NaF) mouth rinse or NaF gel as an adjunct to NaF dentifrice on incipient caries-like lesions in an in situ cross-over design study, with three sessions of 30 days each. Sodium Fluoride 83-98 C-X-C motif chemokine ligand 8 Homo sapiens 100-103 31084774-1 2019 PET with fluorodeoxyglucose and sodium fluoride (NaF) radiotracers has shown a great promise in assessing patients with multiple myeloma (MM). Sodium Fluoride 32-47 C-X-C motif chemokine ligand 8 Homo sapiens 49-52